Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Adults with type 2 diabetes and CVD and CKD - JSON Representation

Raw json | Download

{
  "resourceType" : "Group",
  "id" : "236947",
  "meta" : {
    "versionId" : "71",
    "lastUpdated" : "2025-03-20T18:40:09.616Z"
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 236947</b></p><a name=\"236947\"> </a><a name=\"hc236947\"> </a><a name=\"236947-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 71; Last updated: 2025-03-20 18:40:09+0000</p></div><p><b>Artifact Author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><blockquote><p><b>RelatesTo</b></p><ul><li>type: part-of</li><li>targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</li></ul></blockquote><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/236947\">https://fevir.net/resources/Group/236947</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/236947, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-population-group-85394-85798</p><p><b>name</b>: Adults_with_type_2_diabetes</p><p><b>title</b>: Adults with type 2 diabetes and CVD and CKD</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>membership</b>: Conceptual</p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Computable Publishing®: MAGIC-to-FEvIR Converter"
      }
    },
    {
      "extension" : [
        {
          "url" : "type",
          "valueCode" : "part-of"
        },
        {
          "url" : "targetReference",
          "valueReference" : {
            "type" : "Composition",
            "identifier" : {
              "type" : {
                "text" : "FEvIR Linking Identifier"
              },
              "system" : "https://fevir.net/FLI",
              "value" : "MAGIC-5288-j1Wqrn-conversion-report",
              "assigner" : {
                "display" : "Computable Publishing LLC"
              }
            },
            "display" : "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
          }
        }
      ],
      "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/relates-to"
    }
  ],
  "url" : "https://fevir.net/resources/Group/236947",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "urn:ietf:rfc:3986",
      "value" : "https://fevir.net/FOI/236947",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    },
    {
      "type" : {
        "text" : "FEvIR Linking Identifier"
      },
      "system" : "https://fevir.net/FLI",
      "value" : "MAGIC-5288-j1Wqrn-population-group-85394-85798",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "name" : "Adults_with_type_2_diabetes",
  "title" : "Adults with type 2 diabetes and CVD and CKD",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "membership" : "conceptual"
}